Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program

Stuttering Clinical Trial

— SAS:EIP  

Official title:

The Speech Prosody of People With Stuttering and Developmental Apraxia: the Efficacy of an Intervention Program

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01097161
• Other study ID #: SHA 0097/06
• Status: Completed
• Phase: N/A
• First received: March 31, 2010
• Last updated: April 1, 2010
• Start date: April 2007
• Est. completion date: June 2008

Study information

• Verified date: April 2007
• Source: Federal University of Minas Gerais
• Contact: n/a
• Is FDA regulated: No
• Health authority: Brazil: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

Subjects' utterances were submitted to acoustic analysis before and after the intervention program applied on prosodic basis.

Description:

The study has the aim of developing knowledge, methodology and technique in the prosody area, for its application on the speech therapy, with the assistance of a feedback system - with WinpitchPro (Philippe Martin). A database was constituted on the basis of a patterned corpus (EUROM1) by its translation, recording and editing on .wav format. Throughout model-sentences, an experimental intervention program initiates with the participation of 2 adults with stuttering problem and 2 with apraxia of speech. The efficacy of the therapeutic procedure is tested on the basis of the acoustical and the statistical analyses which have compared the first and the second speech samples taken before and after the twenty (20) therapy sessions held in a prosody approach only.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4
• Est. completion date: June 2008
• Est. primary completion date: October 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Clinical diagnosis of stuttering

• Clinical diagnosis of apraxia of speech

• 18 years of age or older

• Portuguese native language

• Agreement by the participant to enroll on 20 therapy sessions scheduled in a 3 month period

Exclusion Criteria:

• History of major medical illness unrelated to primary diagnosis of developmental stuttering and developmental apraxia of speech

• Significant abnormalities on general physical and neurological examination unrelated to primary diagnosis

Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Apraxias
• Developmental Apraxia of Speech
• Stuttering

Intervention

Behavioral:
• speech therapy with the assistance of an acoustical analysis program
Two weekly speech sessions realized on individual basis for three months period

Locations

Country	Name	City	State
Brazil	R. Grão Pará, 85/404	Belo Horizonte	Minas Gerais

Sponsors (2)

Lead Sponsor	Collaborator
Federal University of Minas Gerais	Fundação de Amparo à Pesquisa do estado de Minas Gerais

Country where clinical trial is conducted

Brazil, 

External Links

•   Conselho nacional de Saúde
•   Fundação de Amparo à pesquisa do Estado de Minas Gerais
•   Laboratório de Fonética da FALE - UFMG